Evommune (EVMN) Capital Leases (2024 - 2026)

Evommune (EVMN) has 3 years of Capital Leases data on file, last reported at $529000.0 in Q1 2026.

• Capital Leases for Q1 2026 came in at $529000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $529000.0 (changed N/A YoY), and the FY2025 annual result was $181000.0, down 66.17% from the prior year.
• Capital Leases advanced to $529000.0 in Q1 2026 per EVMN's latest filing, from $181000.0 in the prior quarter.
• Over five years, Capital Leases peaked at $535000.0 in Q4 2024 and troughed at $181000.0 in Q4 2025.
• A 3-year average of $415000.0 and a median of $529000.0 in 2026 frame the typical range for Capital Leases.
• On a YoY basis, Capital Leases climbed as much as 66.17% in 2025 and fell as far as 66.17% in 2025.
• A 3-year view of Capital Leases shows it stood at $535000.0 in 2024, then plunged by 66.17% to $181000.0 in 2025, then surged by 192.27% to $529000.0 in 2026.
• Business Quant data shows EVMN's Capital Leases at $529000.0 in Q1 2026, $181000.0 in Q4 2025, and $535000.0 in Q4 2024.